These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30519638)

  • 41. De Novo CD5
    Xu Y; Sun W; Li F
    Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e782-e790. PubMed ID: 32694049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma.
    Mitrovic Z; Iqbal J; Fu K; Smith LM; Bast M; Greiner TC; Aoun P; Armitage JO; Vose JM; Weisenburger DD; Chan WC
    Br J Haematol; 2013 Jul; 162(1):87-92. PubMed ID: 23617469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
    Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases.
    Tagawa H; Tsuzuki S; Suzuki R; Karnan S; Ota A; Kameoka Y; Suguro M; Matsuo K; Yamaguchi M; Okamoto M; Morishima Y; Nakamura S; Seto M
    Cancer Res; 2004 Sep; 64(17):5948-55. PubMed ID: 15342373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins.
    Hiratsuka T; Ito S; Sakai R; Yokose T; Endo T; Daigo Y; Miyagi Y; Tsuruyama T
    Clin Proteomics; 2023 Sep; 20(1):36. PubMed ID: 37705009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. B-cell lymphomas with coexpression of CD5 and CD10.
    Dong HY; Gorczyca W; Liu Z; Tsang P; Wu CD; Cohen P; Weisberger J
    Am J Clin Pathol; 2003 Feb; 119(2):218-30. PubMed ID: 12579992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
    Kano R; Masaie H; Hino A; Yasuoka H; Nagata S; Ishikawa J; Nakatsuka SI
    Diagn Pathol; 2018 Jul; 13(1):46. PubMed ID: 30041681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of prognostic factors in patients with diffuse large B-cell lymphoma.
    Peng F; Guo L; Yao WK; Zheng Y; Liu Y; Duan XM; Wang YP
    Indian J Pathol Microbiol; 2017; 60(1):87-91. PubMed ID: 28195099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiogenesis in CD5-positive Diffuse Large B Cell Lymphoma: A Morphometric Analysis.
    Woźnialis N; Gierej B; Popławska L; Ziarkiewicz M; Wolińska E; Kulczycka E; Ziarkiewicz-Wróblewska B
    Adv Clin Exp Med; 2016; 25(6):1149-1155. PubMed ID: 28028967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD43 expression is an adverse prognostic factor in diffuse large B-Cell lymphoma.
    Mitrovic Z; Ilic I; Nola M; Aurer I; Sonicki Z; Basic-Kinda S; Radman I; Ajdukovic R; Labar B
    Clin Lymphoma Myeloma; 2009 Apr; 9(2):133-7. PubMed ID: 19406723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas.
    Zhang A; Ohshima K; Sato K; Kanda M; Suzumiya J; Shimazaki K; Kawasaki C; Kikuchi M
    Pathol Int; 1999 Dec; 49(12):1043-52. PubMed ID: 10632924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD5-positive marginal zone lymphoma: Clinicopathological features and survival outcomes.
    Xia Y; Ge J; Sun Z; Nan F; Wan W; Xu D; Zhang M; Fu X
    Leuk Res; 2022 Jun; 117():106840. PubMed ID: 35468520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization.
    Karnan S; Tagawa H; Suzuki R; Suguro M; Yamaguchi M; Okamoto M; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2004 Jan; 39(1):77-81. PubMed ID: 14603444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Liapis K; Gortzolidis G; Kostopoulos IV; Marinakis T; Paterakis G
    Cytometry B Clin Cytom; 2020 Sep; 98(5):412-420. PubMed ID: 32497402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
    Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
    Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases.
    Tzankov A; Pehrs AC; Zimpfer A; Ascani S; Lugli A; Pileri S; Dirnhofer S
    J Clin Pathol; 2003 Oct; 56(10):747-52. PubMed ID: 14514777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival.
    Yoshioka T; Miura I; Kume M; Takahashi N; Okamoto M; Ichinohasama R; Yoshino T; Yamaguchi M; Hirokawa M; Sawada K; Nakamura S
    Genes Chromosomes Cancer; 2005 Feb; 42(2):149-57. PubMed ID: 15543600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blimp-1 protein and Hans classification on prognosis of diffuse large B-cell lymphoma and their interrelation.
    Song Y; Cao Z; Li L; Zhang HT; Zhang X
    Chin J Cancer; 2010 Sep; 29(9):781-6. PubMed ID: 20800019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China.
    Chen DG; Chen G; Wang C; Ke LF; Wu H; He HM; Yang Y; Chen YP
    Infect Agent Cancer; 2021 Aug; 16(1):57. PubMed ID: 34404436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.